These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 2215698)

  • 1. X-ray structure of phospholipase A2 complexed with a substrate-derived inhibitor.
    Thunnissen MM; Ab E; Kalk KH; Drenth J; Dijkstra BW; Kuipers OP; Dijkman R; de Haas GH; Verheij HM
    Nature; 1990 Oct; 347(6294):689-91. PubMed ID: 2215698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling of substrate and inhibitor binding to phospholipase A2.
    Sessions RB; Dauber-Osguthorpe P; Campbell MM; Osguthorpe DJ
    Proteins; 1992 Sep; 14(1):45-64. PubMed ID: 1409562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of cobra-venom phospholipase A2 in a complex with a transition-state analogue.
    White SP; Scott DL; Otwinowski Z; Gelb MH; Sigler PB
    Science; 1990 Dec; 250(4987):1560-3. PubMed ID: 2274787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular dynamics simulation of a phospholipase A2-substrate complex.
    Jones ST; Ahlström P; Berendsen HJ; Pickersgill RW
    Biochim Biophys Acta; 1993 Mar; 1162(1-2):135-42. PubMed ID: 8448177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMR structures of phospholipase A2 reveal conformational changes during interfacial activation.
    van den Berg B; Tessari M; Boelens R; Dijkman R; de Haas GH; Kaptein R; Verheij HM
    Nat Struct Biol; 1995 May; 2(5):402-6. PubMed ID: 7664098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structures of free and inhibited human secretory phospholipase A2 from inflammatory exudate.
    Scott DL; White SP; Browning JL; Rosa JJ; Gelb MH; Sigler PB
    Science; 1991 Nov; 254(5034):1007-10. PubMed ID: 1948070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phospholipase A2 as a target protein for nonsteroidal anti-inflammatory drugs (NSAIDS): crystal structure of the complex formed between phospholipase A2 and oxyphenbutazone at 1.6 A resolution.
    Singh N; Jabeen T; Somvanshi RK; Sharma S; Dey S; Singh TP
    Biochemistry; 2004 Nov; 43(46):14577-83. PubMed ID: 15544328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of phospholipase A2.
    Gelb MH; Jain MK; Berg OG
    FASEB J; 1994 Sep; 8(12):916-24. PubMed ID: 8088457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of human secretory phospholipase A2-IIA complex with the potent indolizine inhibitor 120-1032.
    Kitadokoro K; Hagishita S; Sato T; Ohtani M; Miki K
    J Biochem; 1998 Apr; 123(4):619-23. PubMed ID: 9538252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of the arachidonic acid cascade through phospholipase A2 dependent mechanisms.
    Dennis EA
    Adv Prostaglandin Thromboxane Leukot Res; 1990; 20():217-23. PubMed ID: 2144695
    [No Abstract]   [Full Text] [Related]  

  • 11. Specific competitive inhibitor of secreted phospholipase A2 from berries of Schinus terebinthifolius.
    Jain MK; Yu BZ; Rogers JM; Smith AE; Boger ET; Ostrander RL; Rheingold AL
    Phytochemistry; 1995 Jun; 39(3):537-47. PubMed ID: 7576451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of bee-venom phospholipase A2 in a complex with a transition-state analogue.
    Scott DL; Otwinowski Z; Gelb MH; Sigler PB
    Science; 1990 Dec; 250(4987):1563-6. PubMed ID: 2274788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First structural evidence of a specific inhibition of phospholipase A2 by alpha-tocopherol (vitamin E) and its implications in inflammation: crystal structure of the complex formed between phospholipase A2 and alpha-tocopherol at 1.8 A resolution.
    Chandra V; Jasti J; Kaur P; Betzel Ch; Srinivasan A; Singh TP
    J Mol Biol; 2002 Jul; 320(2):215-22. PubMed ID: 12079380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secretory phospholipase A2 from Arabidopsis thaliana: insights into the three-dimensional structure and the amino acids involved in catalysis.
    Mansfeld J; Gebauer S; Dathe K; Ulbrich-Hofmann R
    Biochemistry; 2006 May; 45(18):5687-94. PubMed ID: 16669612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural changes in a secretory phospholipase A2 induced by membrane binding: a clue to interfacial activation?
    Tatulian SA; Biltonen RL; Tamm LK
    J Mol Biol; 1997 May; 268(5):809-15. PubMed ID: 9180373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction mode of n-dodecylphosphorylcholine, a substrate analogue, with bovine pancreas phospholipase A2 as determined by X-ray crystal analysis.
    Tomoo K; Ohishi H; Doi M; Ishida T; Inoue M; Ikeda K; Mizuno H
    Biochem Biophys Res Commun; 1992 Sep; 187(2):821-7. PubMed ID: 1530638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-resolution X-ray crystallography reveals precise binding interactions between human nonpancreatic secreted phospholipase A2 and a highly potent inhibitor (FPL67047XX).
    Cha SS; Lee D; Adams J; Kurdyla JT; Jones CS; Marshall LA; Bolognese B; Abdel-Meguid SS; Oh BH
    J Med Chem; 1996 Sep; 39(20):3878-81. PubMed ID: 8831753
    [No Abstract]   [Full Text] [Related]  

  • 18. X-ray crystal structure and molecular dynamics simulation of bovine pancreas phospholipase A2-n-dodecylphosphorylcholine complex.
    Tomoo K; Ohishi H; Ishida T; Inoue M; Ikeda K; Sumiya S; Kitamura K
    Proteins; 1994 Aug; 19(4):330-9. PubMed ID: 7984628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. X-ray crystal structure determination and molecular dynamics simulation of prophospholipase A2 inhibited by amide-type substrate analogues.
    Tomoo K; Yamane A; Ishida T; Fujii S; Ikeda K; Iwama S; Katsumura S; Sumiya S; Miyagawa H; Kitamura K
    Biochim Biophys Acta; 1997 Jul; 1340(2):178-86. PubMed ID: 9252105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of human cytosolic phospholipase A2 reveals a novel topology and catalytic mechanism.
    Dessen A; Tang J; Schmidt H; Stahl M; Clark JD; Seehra J; Somers WS
    Cell; 1999 Apr; 97(3):349-60. PubMed ID: 10319815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.